Biofrontera AG Sales And Marketing Expense
Biofrontera AG reported Sales And Marketing Expense of EUR 20.48 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-04-12.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2021-04-12
| Period end | Sales And Marketing Expense 12 month | Sales And Marketing Expense 12 month as first filed |
|---|---|---|
| 2020-12-31 | 20.48M EUR 20-F · filed 2021-04-12 | |
| 2019-12-31 | 28.86M EUR 20-F · filed 2021-04-12 | |
| 2018-12-31 | 17.74M EUR 20-F · filed 2021-04-12 | |
| 2017-12-31 | 16.92M EUR 20-F · filed 2020-04-21 | 16.90M EUR 20-F · filed 2018-04-30 |
| 2016-12-31 | 8.80M EUR 20-F · filed 2019-04-29 | |
| 2015-12-31 | 4.20M EUR 20-F · filed 2018-04-30 |